Tetraphase Pharmaceuticals Ireland Limited was set up on Tuesday the 24th of October 2017. Their current partial address is Dublin 2, and the company status is Dissolved with the company closing on Monday the 30th of May 2022. The company's current directors have been the director of 151 other Irish companies between them; 93 of which are now closed. Tetraphase Pharmaceuticals Ireland Limited has 1 shareholder. This Irish company shares its Eircode with at least 774 other companies.
| Company Name: | Tetraphase Pharmaceuticals Ireland Limited | |
| Company Status: | DISSOLVED | |
| RiskWatch | CEASED TRADING NOTIFICATION | |
| RiskWatch | CEASED TRADING NOTIFICATION | |
| Company Address: | 10 Earlsfort Terrace, Dublin 2 | |
| Key Executive: | Mr Hayes | |
| Company Size: | Log-In To View | |
| Established: | 24/10/2017 (5 years in business). | |
Mr Hayes is a Company Director of Tetraphase Pharmaceuticals Ireland Limited since 2017 and a listed Director of 84 other companies.
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
The latest documents filed with the Companies Registration Office for Tetraphase Pharmaceuticals Ireland Limited (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| G1H15 SR TO APPLY FOR VOLUNTARY STRIKE OFF | 21/12/2021 | 11/02/2022 | Join Up | |
| Form H15: Application for Voluntary strike-off | 11/02/2022 | 11/02/2022 | Join Up | |
| Form B1C - Annual Return General | 30/09/2021 | 14/01/2022 | Join Up | |
| FINANCIAL STATEMENT | 30/09/2021 | 14/01/2022 | Join Up | |
| Form B1C - Annual Return General | 30/09/2020 | 13/01/2022 | Join Up | |
| THIS COMPANY HAS 10 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
View the Latest Credit Report and Credit Limit on Tetraphase Pharmaceuticals Ireland Limited.
| Company Status: | Dissolved | |
| RiskWatch | CEASED TRADING NOTIFICATION | |
| RiskWatch | CEASED TRADING NOTIFICATION | |
| Latest Credit Movement: | ![]() | |
| Date of Last Movement: | 05/08/2025 | |
| Latest Accounts Filed: | 14/01/2022 | |
| Report Based on Accounts: | 31/12/2020 | |
| Next Set of Accounts Due: | 30/09/2022 | |
| Overdue: | Yes | |
| Credit Score: | Join-Up to View | |
To View the latest Credit Rating or Credit Limit on Tetraphase Pharmaceuticals Ireland Limited simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Satisfy due diligence requirements on Tetraphase Pharmaceuticals Ireland Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Tetraphase Pharmaceuticals Ireland Limited and Anti-Money Laundering checks (AML checks) on Tetraphase Pharmaceuticals Ireland Limited
| Company Type: | LTD - Private Company Limited By Shares |
| Number of Shareholders: | 1 |
Log-in now to run Due Diligence checks and Compliance checks on Tetraphase Pharmaceuticals Ireland Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

01/05/2026
In today’s trading environment, risk rarely presents itself in a single moment. Credit profiles shift, financial resilience weakens, and company status changes can occur quietly in the background.

27/04/2026
As we recently marked Earth Day 2026, the focus on sustainability has highlighted a simple reality: ESG is now a practical part of everyday business decision-making.

17/04/2026
While strong new business formation set a positive tone for the opening quarter of 2026, the wider financial and governance picture reveals a more nuanced environment.

08/04/2026
The first quarter of 2026 offers a clear view of how Irish entrepreneurs are responding to a challenging economic environment.